CIK 0001422142
- Non-accelerated filer
- Smaller reporting company
Whitehawk Therapeutics, Inc.
Sign in to watch- Ticker
- WHWK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 611547850
- Phone
- +1 551-321-2234
- Business address
- 2 HEADQUARTERS PLAZA, EAST BUILDING, 11TH FLOOR, MORRISTOWN, NJ, 07960
- Former names
- Aadi Bioscience, Inc., Aerpio Pharmaceuticals, Inc., ZETA ACQUISITION CORP II
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4/A Open-market buy Director bought 1,529,402 shares at $13.08 ($19,999,990)
- 4 Open-market buy Director bought 259,998 shares at $13.08 ($3,399,994)
- 4 Open-market buy Director bought 1,529,402 shares at $13.08 ($19,999,990)
- 4 Grant or award Director acquired 1,911,752 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 7,400 shares (grant or award)
- 4 Grant or award Director acquired 12,334 shares (grant or award)
- 4 Grant or award Director acquired 6,331 shares (grant or award)
- 4 Grant or award Director acquired 7,811 shares (grant or award)
- 4 Grant or award Director acquired 8,140 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 8,020 shares (grant or award)
- 4 Grant or award Director acquired 7,290 shares (grant or award)
- 4 Grant or award Director acquired 6,237 shares (grant or award)
- 4 Grant or award Director acquired 12,151 shares (grant or award)
- 4 Grant or award Director acquired 7,696 shares (grant or award)
- 4 Derivatives Options or other derivatives
Page 8 of 14 · 263 filings